SEC Form 4 · accession 0001123292-18-000509
OSIRIS THERAPEUTICS, INC. · OSIR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shauna L Vernal
Officer — Chief Legal Officer
Period of report
Mar 6, 2018
Accepted (ET)
Mar 8, 2018 · 10:33 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001360886
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $8.95 | Mar 6, 2018 | A | 20,000 | A | Mar 6, 2019 | Mar 5, 2028 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F125% of the shares underlying this option shall vest on each of March 06, 2019, March 06, 2020, March 06, 2021 and March 06, 2022, subject to Reporting Person's continued service through the applicable vesting date.